nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB1—dilated cardiomyopathy	0.414	0.543	CbGaD
Metoprolol—ADRB2—dilated cardiomyopathy	0.348	0.457	CbGaD
Metoprolol—ABCB1—Lisinopril—dilated cardiomyopathy	0.0576	0.532	CbGbCtD
Metoprolol—ABCB1—Spironolactone—dilated cardiomyopathy	0.0507	0.468	CbGbCtD
Metoprolol—Auditory disorder NOS—Furosemide—dilated cardiomyopathy	0.00831	0.0752	CcSEcCtD
Metoprolol—Hepatic cirrhosis—Furosemide—dilated cardiomyopathy	0.00587	0.0531	CcSEcCtD
Metoprolol—Acute myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00462	0.0418	CcSEcCtD
Metoprolol—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.00242	0.0218	CcSEcCtD
Metoprolol—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.00191	0.0173	CcSEcCtD
Metoprolol—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00172	0.0155	CcSEcCtD
Metoprolol—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00151	0.0136	CcSEcCtD
Metoprolol—SLC22A2—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00145	0.141	CbGpPWpGaD
Metoprolol—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00135	0.0122	CcSEcCtD
Metoprolol—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00134	0.0121	CcSEcCtD
Metoprolol—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.0013	0.0117	CcSEcCtD
Metoprolol—Heartburn—Lisinopril—dilated cardiomyopathy	0.00123	0.0111	CcSEcCtD
Metoprolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00119	0.0108	CcSEcCtD
Metoprolol—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00118	0.0107	CcSEcCtD
Metoprolol—Throat sore—Lisinopril—dilated cardiomyopathy	0.00117	0.0106	CcSEcCtD
Metoprolol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00116	0.0105	CcSEcCtD
Metoprolol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00108	0.00976	CcSEcCtD
Metoprolol—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00108	0.00972	CcSEcCtD
Metoprolol—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00101	0.0091	CcSEcCtD
Metoprolol—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000981	0.0959	CbGpPWpGaD
Metoprolol—Mental disability—Furosemide—dilated cardiomyopathy	0.000976	0.00883	CcSEcCtD
Metoprolol—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000939	0.00849	CcSEcCtD
Metoprolol—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00093	0.00841	CcSEcCtD
Metoprolol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000928	0.00839	CcSEcCtD
Metoprolol—Alopecia—Spironolactone—dilated cardiomyopathy	0.000917	0.0083	CcSEcCtD
Metoprolol—Deafness—Furosemide—dilated cardiomyopathy	0.000913	0.00825	CcSEcCtD
Metoprolol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000869	0.00786	CcSEcCtD
Metoprolol—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000854	0.00772	CcSEcCtD
Metoprolol—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000844	0.00763	CcSEcCtD
Metoprolol—Wheezing—Lisinopril—dilated cardiomyopathy	0.00082	0.00741	CcSEcCtD
Metoprolol—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000809	0.00732	CcSEcCtD
Metoprolol—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000755	0.00683	CcSEcCtD
Metoprolol—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000746	0.00674	CcSEcCtD
Metoprolol—Confusional state—Spironolactone—dilated cardiomyopathy	0.000744	0.00673	CcSEcCtD
Metoprolol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000735	0.00665	CcSEcCtD
Metoprolol—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000722	0.00653	CcSEcCtD
Metoprolol—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000708	0.0064	CcSEcCtD
Metoprolol—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000704	0.00637	CcSEcCtD
Metoprolol—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000701	0.00634	CcSEcCtD
Metoprolol—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000698	0.00631	CcSEcCtD
Metoprolol—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000661	0.00597	CcSEcCtD
Metoprolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.000658	0.0643	CbGpPWpGaD
Metoprolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000656	0.00593	CcSEcCtD
Metoprolol—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000644	0.00582	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000637	0.00576	CcSEcCtD
Metoprolol—Arthritis—Lisinopril—dilated cardiomyopathy	0.00063	0.0057	CcSEcCtD
Metoprolol—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000628	0.00568	CcSEcCtD
Metoprolol—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000625	0.00565	CcSEcCtD
Metoprolol—Practolol—ADRB1—dilated cardiomyopathy	0.000609	0.0685	CrCbGaD
Metoprolol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000608	0.0055	CcSEcCtD
Metoprolol—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000608	0.0055	CcSEcCtD
Metoprolol—Sweating—Furosemide—dilated cardiomyopathy	0.000603	0.00545	CcSEcCtD
Metoprolol—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000595	0.00538	CcSEcCtD
Metoprolol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000587	0.00531	CcSEcCtD
Metoprolol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000586	0.0053	CcSEcCtD
Metoprolol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000583	0.00527	CcSEcCtD
Metoprolol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000583	0.00527	CcSEcCtD
Metoprolol—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00056	0.00506	CcSEcCtD
Metoprolol—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000554	0.00501	CcSEcCtD
Metoprolol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000552	0.00499	CcSEcCtD
Metoprolol—Metipranolol—ADRB1—dilated cardiomyopathy	0.00055	0.062	CrCbGaD
Metoprolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.000545	0.0533	CbGpPWpGaD
Metoprolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000544	0.00492	CcSEcCtD
Metoprolol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000543	0.00491	CcSEcCtD
Metoprolol—Eye disorder—Furosemide—dilated cardiomyopathy	0.000528	0.00477	CcSEcCtD
Metoprolol—Tinnitus—Furosemide—dilated cardiomyopathy	0.000527	0.00476	CcSEcCtD
Metoprolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000522	0.00472	CcSEcCtD
Metoprolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000521	0.00471	CcSEcCtD
Metoprolol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000516	0.00466	CcSEcCtD
Metoprolol—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000516	0.00466	CcSEcCtD
Metoprolol—Angiopathy—Furosemide—dilated cardiomyopathy	0.000512	0.00463	CcSEcCtD
Metoprolol—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00051	0.00461	CcSEcCtD
Metoprolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000505	0.00456	CcSEcCtD
Metoprolol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000505	0.00456	CcSEcCtD
Metoprolol—Sotalol—ADRB1—dilated cardiomyopathy	0.000491	0.0552	CrCbGaD
Metoprolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000488	0.00441	CcSEcCtD
Metoprolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000488	0.00441	CcSEcCtD
Metoprolol—Flatulence—Furosemide—dilated cardiomyopathy	0.000485	0.00438	CcSEcCtD
Metoprolol—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000483	0.00437	CcSEcCtD
Metoprolol—Weight increased—Lisinopril—dilated cardiomyopathy	0.000482	0.00436	CcSEcCtD
Metoprolol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000482	0.00435	CcSEcCtD
Metoprolol—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000475	0.00429	CcSEcCtD
Metoprolol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000473	0.00428	CcSEcCtD
Metoprolol—Depression—Lisinopril—dilated cardiomyopathy	0.000471	0.00426	CcSEcCtD
Metoprolol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000469	0.00424	CcSEcCtD
Metoprolol—Rash—Spironolactone—dilated cardiomyopathy	0.000465	0.00421	CcSEcCtD
Metoprolol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000465	0.0042	CcSEcCtD
Metoprolol—Vision blurred—Furosemide—dilated cardiomyopathy	0.000463	0.00419	CcSEcCtD
Metoprolol—Metipranolol—ADRB2—dilated cardiomyopathy	0.000463	0.0521	CrCbGaD
Metoprolol—Headache—Spironolactone—dilated cardiomyopathy	0.000462	0.00418	CcSEcCtD
Metoprolol—Jaundice—Lisinopril—dilated cardiomyopathy	0.00046	0.00416	CcSEcCtD
Metoprolol—Sweating—Lisinopril—dilated cardiomyopathy	0.000453	0.00409	CcSEcCtD
Metoprolol—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000447	0.00404	CcSEcCtD
Metoprolol—Vertigo—Furosemide—dilated cardiomyopathy	0.000442	0.00399	CcSEcCtD
Metoprolol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000441	0.00398	CcSEcCtD
Metoprolol—Leukopenia—Furosemide—dilated cardiomyopathy	0.00044	0.00398	CcSEcCtD
Metoprolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000438	0.00396	CcSEcCtD
Metoprolol—Esmolol—ADRB1—dilated cardiomyopathy	0.000437	0.0492	CrCbGaD
Metoprolol—Bevantolol—ADRB1—dilated cardiomyopathy	0.000432	0.0486	CrCbGaD
Metoprolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000431	0.0039	CcSEcCtD
Metoprolol—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000425	0.00384	CcSEcCtD
Metoprolol—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000424	0.00383	CcSEcCtD
Metoprolol—Hallucination—Lisinopril—dilated cardiomyopathy	0.000422	0.00381	CcSEcCtD
Metoprolol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000418	0.00378	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000416	0.00376	CcSEcCtD
Metoprolol—Sotalol—ADRB2—dilated cardiomyopathy	0.000413	0.0464	CrCbGaD
Metoprolol—Dry mouth—Furosemide—dilated cardiomyopathy	0.000409	0.0037	CcSEcCtD
Metoprolol—Confusional state—Furosemide—dilated cardiomyopathy	0.000405	0.00366	CcSEcCtD
Metoprolol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000395	0.00357	CcSEcCtD
Metoprolol—Shock—Furosemide—dilated cardiomyopathy	0.000395	0.00357	CcSEcCtD
Metoprolol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000394	0.00356	CcSEcCtD
Metoprolol—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000393	0.00355	CcSEcCtD
Metoprolol—Skin disorder—Furosemide—dilated cardiomyopathy	0.00039	0.00352	CcSEcCtD
Metoprolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000388	0.00351	CcSEcCtD
Metoprolol—Betaxolol—ADRB1—dilated cardiomyopathy	0.000385	0.0433	CrCbGaD
Metoprolol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000385	0.00348	CcSEcCtD
Metoprolol—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000382	0.00345	CcSEcCtD
Metoprolol—Atenolol—ADRB1—dilated cardiomyopathy	0.000382	0.0429	CrCbGaD
Metoprolol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000379	0.00342	CcSEcCtD
Metoprolol—Hypotension—Furosemide—dilated cardiomyopathy	0.000375	0.00339	CcSEcCtD
Metoprolol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000375	0.00339	CcSEcCtD
Metoprolol—Bisoprolol—ADRB1—dilated cardiomyopathy	0.000372	0.0418	CrCbGaD
Metoprolol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000371	0.00336	CcSEcCtD
Metoprolol—Esmolol—ADRB2—dilated cardiomyopathy	0.000368	0.0414	CrCbGaD
Metoprolol—Flatulence—Lisinopril—dilated cardiomyopathy	0.000364	0.00329	CcSEcCtD
Metoprolol—Bevantolol—ADRB2—dilated cardiomyopathy	0.000363	0.0409	CrCbGaD
Metoprolol—Tension—Lisinopril—dilated cardiomyopathy	0.000362	0.00327	CcSEcCtD
Metoprolol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000361	0.00327	CcSEcCtD
Metoprolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00036	0.00326	CcSEcCtD
Metoprolol—Nervousness—Lisinopril—dilated cardiomyopathy	0.000358	0.00324	CcSEcCtD
Metoprolol—Somnolence—Furosemide—dilated cardiomyopathy	0.000357	0.00323	CcSEcCtD
Metoprolol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000355	0.00321	CcSEcCtD
Metoprolol—Acebutolol—ADRB1—dilated cardiomyopathy	0.000352	0.0396	CrCbGaD
Metoprolol—Oxprenolol—ADRB1—dilated cardiomyopathy	0.00035	0.0393	CrCbGaD
Metoprolol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000348	0.00314	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000346	0.00313	CcSEcCtD
Metoprolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000346	0.00313	CcSEcCtD
Metoprolol—Constipation—Furosemide—dilated cardiomyopathy	0.000343	0.0031	CcSEcCtD
Metoprolol—Pain—Furosemide—dilated cardiomyopathy	0.000343	0.0031	CcSEcCtD
Metoprolol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000331	0.003	CcSEcCtD
Metoprolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000331	0.00299	CcSEcCtD
Metoprolol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000331	0.00299	CcSEcCtD
Metoprolol—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00033	0.00299	CcSEcCtD
Metoprolol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000328	0.00297	CcSEcCtD
Metoprolol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000326	0.00295	CcSEcCtD
Metoprolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000324	0.00293	CcSEcCtD
Metoprolol—Betaxolol—ADRB2—dilated cardiomyopathy	0.000324	0.0364	CrCbGaD
Metoprolol—Atenolol—ADRB2—dilated cardiomyopathy	0.000321	0.0361	CrCbGaD
Metoprolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.00032	0.036	CrCbGaD
Metoprolol—Urticaria—Furosemide—dilated cardiomyopathy	0.000319	0.00288	CcSEcCtD
Metoprolol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000317	0.00287	CcSEcCtD
Metoprolol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000317	0.00287	CcSEcCtD
Metoprolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000314	0.00284	CcSEcCtD
Metoprolol—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000314	0.00284	CcSEcCtD
Metoprolol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000313	0.00283	CcSEcCtD
Metoprolol—Bisoprolol—ADRB2—dilated cardiomyopathy	0.000313	0.0352	CrCbGaD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000312	0.00282	CcSEcCtD
Metoprolol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000307	0.00278	CcSEcCtD
Metoprolol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000304	0.00275	CcSEcCtD
Metoprolol—Oedema—Lisinopril—dilated cardiomyopathy	0.000301	0.00272	CcSEcCtD
Metoprolol—Shock—Lisinopril—dilated cardiomyopathy	0.000296	0.00268	CcSEcCtD
Metoprolol—Acebutolol—ADRB2—dilated cardiomyopathy	0.000296	0.0333	CrCbGaD
Metoprolol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000296	0.00267	CcSEcCtD
Metoprolol—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000295	0.00267	CcSEcCtD
Metoprolol—Oxprenolol—ADRB2—dilated cardiomyopathy	0.000294	0.0331	CrCbGaD
Metoprolol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000294	0.00266	CcSEcCtD
Metoprolol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000292	0.00264	CcSEcCtD
Metoprolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000291	0.00263	CcSEcCtD
Metoprolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000288	0.0026	CcSEcCtD
Metoprolol—Pruritus—Furosemide—dilated cardiomyopathy	0.000284	0.00257	CcSEcCtD
Metoprolol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000281	0.00254	CcSEcCtD
Metoprolol—Pindolol—ADRB1—dilated cardiomyopathy	0.000275	0.031	CrCbGaD
Metoprolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000275	0.00248	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000274	0.00248	CcSEcCtD
Metoprolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000272	0.00246	CcSEcCtD
Metoprolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00027	0.00244	CcSEcCtD
Metoprolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000269	0.0303	CrCbGaD
Metoprolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000268	0.00243	CcSEcCtD
Metoprolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000268	0.00242	CcSEcCtD
Metoprolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000265	0.0024	CcSEcCtD
Metoprolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000265	0.0024	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00026	0.00235	CcSEcCtD
Metoprolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.00026	0.00235	CcSEcCtD
Metoprolol—Pain—Lisinopril—dilated cardiomyopathy	0.000257	0.00233	CcSEcCtD
Metoprolol—Constipation—Lisinopril—dilated cardiomyopathy	0.000257	0.00233	CcSEcCtD
Metoprolol—Vomiting—Furosemide—dilated cardiomyopathy	0.000255	0.00231	CcSEcCtD
Metoprolol—Rash—Furosemide—dilated cardiomyopathy	0.000253	0.00229	CcSEcCtD
Metoprolol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000253	0.00229	CcSEcCtD
Metoprolol—Headache—Furosemide—dilated cardiomyopathy	0.000251	0.00227	CcSEcCtD
Metoprolol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000248	0.00224	CcSEcCtD
Metoprolol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000246	0.00223	CcSEcCtD
Metoprolol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000239	0.00216	CcSEcCtD
Metoprolol—Nausea—Furosemide—dilated cardiomyopathy	0.000238	0.00216	CcSEcCtD
Metoprolol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000238	0.00215	CcSEcCtD
Metoprolol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000238	0.00215	CcSEcCtD
Metoprolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000233	0.0228	CbGpPWpGaD
Metoprolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000231	0.026	CrCbGaD
Metoprolol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000222	0.00201	CcSEcCtD
Metoprolol—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000221	0.0216	CbGpPWpGaD
Metoprolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000216	0.00195	CcSEcCtD
Metoprolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000213	0.00193	CcSEcCtD
Metoprolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000206	0.00186	CcSEcCtD
Metoprolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000199	0.0018	CcSEcCtD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000196	0.0192	CbGpPWpGaD
Metoprolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000196	0.0191	CbGpPWpGaD
Metoprolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000193	0.0188	CbGpPWpGaD
Metoprolol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000191	0.00173	CcSEcCtD
Metoprolol—Rash—Lisinopril—dilated cardiomyopathy	0.00019	0.00172	CcSEcCtD
Metoprolol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00019	0.00172	CcSEcCtD
Metoprolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.00019	0.0185	CbGpPWpGaD
Metoprolol—Headache—Lisinopril—dilated cardiomyopathy	0.000189	0.00171	CcSEcCtD
Metoprolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000179	0.00162	CcSEcCtD
Metoprolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000162	0.0158	CbGpPWpGaD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000151	0.0147	CbGpPWpGaD
Metoprolol—Propranolol—ADRB1—dilated cardiomyopathy	0.00015	0.0169	CrCbGaD
Metoprolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.00015	0.0146	CbGpPWpGaD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000147	0.0144	CbGpPWpGaD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000146	0.0143	CbGpPWpGaD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000143	0.014	CbGpPWpGaD
Metoprolol—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00014	0.0137	CbGpPWpGaD
Metoprolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000137	0.0134	CbGpPWpGaD
Metoprolol—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000129	0.0126	CbGpPWpGaD
Metoprolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000126	0.0142	CrCbGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000121	0.0119	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000119	0.0116	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000107	0.0104	CbGpPWpGaD
Metoprolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	9.92e-05	0.0097	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	9.82e-05	0.0096	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	8.93e-05	0.00873	CbGpPWpGaD
Metoprolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	8.07e-05	0.00789	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	7.85e-05	0.00767	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	7.52e-05	0.00736	CbGpPWpGaD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	6.97e-05	0.00681	CbGpPWpGaD
Metoprolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	6.68e-05	0.00654	CbGpPWpGaD
Metoprolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	6.35e-05	0.00621	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.24e-05	0.00611	CbGpPWpGaD
Metoprolol—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	6.23e-05	0.00609	CbGpPWpGaD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	5.88e-05	0.00575	CbGpPWpGaD
Metoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	5.77e-05	0.00564	CbGpPWpGaD
Metoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	5.75e-05	0.00562	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.25e-05	0.00514	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.1e-05	0.00499	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	4.99e-05	0.00488	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	4.74e-05	0.00464	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.66e-05	0.00456	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	4.64e-05	0.00453	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.54e-05	0.00444	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.54e-05	0.00444	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	4.49e-05	0.00439	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.4e-05	0.0043	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.37e-05	0.00427	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.37e-05	0.00427	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.27e-05	0.00418	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.27e-05	0.00418	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.22e-05	0.00413	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.09e-05	0.004	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.06e-05	0.00397	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	3.97e-05	0.00388	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.95e-05	0.00386	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	3.92e-05	0.00383	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.85e-05	0.00377	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	3.85e-05	0.00376	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	3.84e-05	0.00375	CbGpPWpGaD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	3.72e-05	0.00364	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.62e-05	0.00354	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.36e-05	0.00328	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.33e-05	0.00325	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.33e-05	0.00325	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.29e-05	0.00321	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.25e-05	0.00318	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.25e-05	0.00318	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	3.19e-05	0.00312	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.09e-05	0.00302	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.07e-05	0.003	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.03e-05	0.00296	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.93e-05	0.00287	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	2.88e-05	0.00282	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	2.61e-05	0.00255	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.56e-05	0.0025	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.55e-05	0.00249	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.5e-05	0.00245	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.48e-05	0.00242	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.48e-05	0.00242	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	2.43e-05	0.00237	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.36e-05	0.00231	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.31e-05	0.00226	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.3e-05	0.00225	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.23e-05	0.00218	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.02e-05	0.00197	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.95e-05	0.0019	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.91e-05	0.00187	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.88e-05	0.00184	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.88e-05	0.00184	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.84e-05	0.0018	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.84e-05	0.0018	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	1.8e-05	0.00176	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	1.76e-05	0.00172	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.75e-05	0.00171	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.72e-05	0.00168	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	1.71e-05	0.00167	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.71e-05	0.00167	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.71e-05	0.00167	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.71e-05	0.00167	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.68e-05	0.00164	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.67e-05	0.00164	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.67e-05	0.00163	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.67e-05	0.00163	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.66e-05	0.00162	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.61e-05	0.00158	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.59e-05	0.00155	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.58e-05	0.00154	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.57e-05	0.00154	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.55e-05	0.00152	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.5e-05	0.00147	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.48e-05	0.00145	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.46e-05	0.00143	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.45e-05	0.00141	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.42e-05	0.00139	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.41e-05	0.00138	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.37e-05	0.00134	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.34e-05	0.00131	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.31e-05	0.00128	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.28e-05	0.00126	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.27e-05	0.00124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.25e-05	0.00122	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.14e-05	0.00111	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.11e-05	0.00109	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.06e-05	0.00104	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.04e-05	0.00102	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.02e-05	0.000995	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.01e-05	0.000986	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.01e-05	0.000986	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.95e-06	0.000973	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.86e-06	0.000965	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.86e-06	0.000965	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.67e-06	0.000945	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.46e-06	0.000925	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.37e-06	0.000917	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	9.24e-06	0.000903	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.2e-06	0.0009	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.17e-06	0.000897	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	9.04e-06	0.000884	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.9e-06	0.00087	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.88e-06	0.000869	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.68e-06	0.000849	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.67e-06	0.000848	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.27e-06	0.000809	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.8e-06	0.000763	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.75e-06	0.000758	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.59e-06	0.000742	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.36e-06	0.000719	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	7.08e-06	0.000693	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	6.9e-06	0.000674	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.41e-06	0.000627	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.32e-06	0.000618	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.27e-06	0.000613	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	6.21e-06	0.000607	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.18e-06	0.000605	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.71e-06	0.000558	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	5.59e-06	0.000546	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	5.46e-06	0.000534	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	5.34e-06	0.000522	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.03e-06	0.000492	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.4e-06	0.00043	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.3e-06	0.000421	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.96e-06	0.000388	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.87e-06	0.000378	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.86e-06	0.000378	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.79e-06	0.00037	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.77e-06	0.000368	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.7e-06	0.000362	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.65e-06	0.000357	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.55e-06	0.000347	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.48e-06	0.00034	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.39e-06	0.000332	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.2e-06	0.000313	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.6e-06	0.000254	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.54e-06	0.000248	CbGpPWpGaD
